Chip Davis replaces Ralph Neas, who led Generic Pharmaceutical Association since 2011; Sees broad advocacy needs Davis The $13 million-revenue Generic Pharmaceutical Association has named Chester "Chip" Davis president and CEO, effective Aug. 18. He replaces Ralph Neas, who has led the group for four years. Davis is currently EVP for advocacy at $205 million-revenue Pharmaceutical Research and Manufacturers of America. He said he's anxious to advocate "safe, effective and affordable" generic drugs at the state, federal and international levels. "From policymakers to patients to providers, discussions on how to promote access while simultaneously generating health… Read More